Home | HealthCare Royalty Partners

Advancing Biopharmaceutical Innovation with Creative Capital Solutions

KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing its Life Sciences Strategy

Click here for press release

Royalty Monetization

Corporate Financing

$7B+

Committed in more than 110 biopharma products since inception

NY

New York Metro Area

CA

San Francisco

MA

Boston

UK

London

35

Team Members

Meet Our Team

Team

Interview with Dr. Robert Langer, HCRx Senior Advisor

Interview with Gary Lyons, HCRx Senior Advisor

Interview with Dr. Greg Went, Former Chairman & CEO, Adamas Pharmaceuticals (December 2017)

Interview with Julie McHugh, HCRx Senior Advisor

Interview with Julie Anne Smith, Former President and CEO, Raptor Pharmaceuticals

Interview with Nat Ricciardi, HCRx Senior Advisor

Spotlight

Latest News

Duke Professor Reinvests Royalties into New Research

KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing its Life Sciences Strategy

BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty

REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan

Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics